Klebsiella pneumoniae recombinant bacterium with high hydrogen production capacity and construction method of Klebsiella pneumoniae recombinant bacterium

By knocking out the budC gene of Klebsiella pneumoniae strain, a recombinant bacteria with high hydrogen production capacity was constructed, which solved the problems of high consumption and high cost of existing hydrogen production technology, significantly improved hydrogen production, and realized the resource utilization of agricultural straw , reducing environmental pollution and promoting the development of clean energy.

CN119040236AInactive Publication Date: 2024-11-29INNER MONGOLIA UNIV OF TECH
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411457242.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-18
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing hydrogen production technology has problems such as high power consumption, high cost and difficulty. Bio-hydrogen production technology has not fully utilized its potential for clean and renewable energy while utilizing agricultural straw resources.

Method used

By knocking out the budC gene of Klebsiella pneumoniae strain Klebsiellapneumoniae Y7-3, we construct the Klebsiella pneumoniae recombinant bacteria with high hydrogen production capacity and improve its hydrogen production. The specific method includes inserting the budC homologous arm gene into the plasmid and verifying sequencing. Later, it was transferred to the strain, electroconversion and sucrose plate screening, and recombinant bacteria with improved hydrogen production capacity were obtained.

Benefits of technology

It significantly increased the hydrogen production of Klebsiella pneumoniae, expanded its application potential in production, and provided a reference for the study of hydrogen production mechanism, realized the resource utilization of agricultural straw, and reduced environmental pollution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040236A_ABST
    Figure CN119040236A_ABST
Patent Text Reader

Abstract

The invention discloses a Klebsiella pneumoniae recombinant bacterium with high hydrogen production capacity and a construction method thereof, and relates to the technical field of biology, and the recombinant bacterium is obtained by taking Klebsiella pneumoniae Y7-3 as an original strain and knocking out a budC gene with the sequence number of SEQ ID NO.1. The invention further discloses a preparation method of the Klebsiella pneumoniae recombinant bacterium. The preparation method of the recombinant bacterium comprises the following steps: S1, inserting homologous arm genes of budC into plasmids with kanamycin resistance to obtain recombinant plasmids, and verifying and sequencing the recombinant plasmids; s2, transferring the recombinant plasmid into competent cells of a (Klebsiella pneumoniae) Y7-3 strain, and carrying out primary screening on a solid resistance plate containing kanamycin resistance, so as to obtain a single exchange strain; and S3, coating a sucrose plate with the single-exchange strain to obtain a double-exchange strain, namely the klebsiella pneumoniae recombinant strain. According to the recombinant bacterium provided by the invention, the hydrogen production capacity of the klebsiella pneumoniae can be improved, the application of the klebsiella pneumoniae as an engineering bacterium in production can be expanded, and a reference can be provided for researching a hydrogen production mechanism of the klebsiella pneumoniae.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to a recombinant Klebsiella pneumoniae bacterium with high hydrogen production capacity and a construction method thereof. Background Art

[0002] In today's society, energy issues have become a major challenge affecting the development of human society and the quality of life. With the continuous growth of the world's population and economy, the accelerated development of urbanization has led to a continuous increase in the demand for energy. However, at present, humans mainly rely on fossil energy to meet the growing energy demand. This has not only led to the depletion of fossil energy, but also faced an increasing resource crisis, but also caused a large amount of greenhouse gas emissions and global climate change, bringing huge environmental risks and economic losses to human society. Therefore, the problem that needs to be solved urgently is how to use clean, sustainable and renewable energy to replace traditional fossil energy.

[0003] Among many renewable energy sources, hydrogen energy is a clean energy with great potential and prospects. The calorific value of H2 is as high as 142 kJ / g, which is one of the fuels with the highest known calorific value. It has been widely used in power generation, energy storage, transportation and other fields. With the development of hydrogen power generation, hydrogen batteries, hydrogen vehicles and hydrogen energy storage, various hydrogen production technologies have also been continuously developed, mainly including electrolysis, photolysis, thermal decomposition and biohydrogen production. Among them, electrolysis is one of the most mature hydrogen production technologies, but it consumes a lot of electricity; photolysis and thermal decomposition are technologies that use solar energy or nuclear energy to decompose water or other compounds to produce hydrogen, but these two technologies are difficult and costly and have not yet been commercialized; biohydrogen production is a new type of hydrogen production technology that uses biomass such as microorganisms or plants to produce hydrogen. It has the advantages of mild reaction conditions, a wide range of raw materials, complete renewable sources, and environmental friendliness.

[0004] my country's total annual biomass energy is about 3.494 billion tons, of which the theoretical amount of straw resources is about 829 million tons and the collectible resources are about 694 million tons. Long-term stacking is prone to cause fire or burning and pollute the environment. How to make use of agricultural straw as a resource has become a hot topic in research. Using biohydrogen production to convert these corn straw resources into high-value-added hydrogen energy will not only avoid waste but also reduce environmental pollution caused by improper straw treatment. Summary of the invention

[0005] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a recombinant Klebsiella pneumoniae with high hydrogen production capacity and a method for constructing the same. Klebsiella pneumoniae )Y7-3 strain was used as the starting strain for transformation to obtain a recombinant Klebsiella pneumoniae with high hydrogen production ability.

[0006] To achieve the above purpose, the technical solution adopted by the present invention is as follows: A recombinant Klebsiella pneumoniae with high hydrogen production capacity is based on Klebsiella pneumoniae ( Klebsiella pneumoniae )Y7-3 is the starting strain, and the sequence number is SEQ ID NO.1. budC Gene acquired.

[0007] Furthermore, the recombinant Klebsiella pneumoniae was named ( Klebsiella pneumoniae ) Y7-3-ΔbudC-2096, and was deposited in Guangdong Provincial Microbiological Culture Collection Center on June 28, 2024, with the deposit number GDMCC NO: 64811, and the deposit address is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou.

[0008] The present invention also provides a method for constructing the above-mentioned recombinant Klebsiella pneumoniae with high hydrogen production ability, comprising: S1: budC The homologous arm gene of the gene was inserted into a plasmid with kanamycin resistance to obtain a recombinant plasmid, and the recombinant plasmid was verified and sequenced; S2: Transform the recombinant plasmid after verification and sequencing into ( Klebsiella pneumoniae )Y7-3 strain competent cells, and primary screening was performed on a solid resistance plate containing kanamycin resistance to obtain a single exchange strain; S3: The single-exchange strain is spread on a sucrose plate to obtain a double-exchange strain, that is, the recombinant Klebsiella pneumoniae is obtained.

[0009] Furthermore, the plasmid in step S1 is pK18mobSacB×101-2096 plasmid, and budC The homology arm gene was inserted between the BamH I and Hind III restriction sites of the plasmid.

[0010] Further, in step S2 ( Klebsiella pneumoniae ) The method for preparing competent cells of Y7-3 strain is: S21: Pick ( Klebsiella pneumoniae ) A single colony of Y7-3 was cultured in LB medium at 37°C on a shaker for 12 h; S22: Take 1 mL of the bacterial culture after shaking and transfer it to 100 mL of LB medium. Shake vigorously at 37°C until OD 600 =0.6; S23: Transfer the cultured bacterial solution in step S22 to a 50 mL centrifuge tube, centrifuge at 8000 rpm and 4°C for 5 min; discard the supernatant, add 5 mL of pre-cooled and sterilized 10% glycerol to resuspend the cells, repeat the operation three times, and then resuspend with 1 mL of pre-cooled 10% sterile glycerol, and then aliquot to obtain ( Klebsiella pneumoniae ) Competent cells of Y7-3 strain.

[0011] Furthermore, in step S2, the solid resistance plate contains kanamycin with a final concentration of 100 mg / L.

[0012] Furthermore, in step S3, the single exchange strain needs to be cultured to the logarithmic phase and then spread on a plate containing 10% sucrose.

[0013] Further, in step S2, the recombinant plasmid is transferred into ( Klebsiella pneumoniae )Y7-3 strain competent cells; the electroporation conditions were: 2.5 KV, 800 Ω, 1 ms.

[0014] Compared with the prior art, the present invention has the following beneficial effects: The present invention is based on Klebsiella pneumoniae ( Klebsiella pneumoniae )Y7-3 was used as the starting bacterium for modification to obtain a recombinant Klebsiella pneumoniae with improved hydrogen production capacity, which can expand the application of Klebsiella pneumoniae as an engineered bacterium in production and provide a reference for studying the mechanism of hydrogen production by Klebsiella pneumoniae. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 This is a diagram showing the results of the Klebsiella pneumoniae Y7-3 gene knockout validation; Figure 2 This is a graph showing the results of hydrogen content determination of the recombinant bacteria. DETAILED DESCRIPTION

[0016] The present invention is further described below in conjunction with the accompanying drawings and embodiments. The embodiments of the present invention include but are not limited to the following embodiments.

[0017] This embodiment provides a recombinant Klebsiella pneumoniae with high hydrogen production capacity by selecting a suitable Klebsiella pneumoniae strain to delete budC Genes were added to increase the hydrogen production efficiency of the strain.

[0018] In this example, a high hydrogen-producing Klebsiella pneumoniae strain was first screened from the bovine rumen and named Klebsiella pneumoniae Y7-3 is deposited in China Center for Type Culture Collection, with the deposit number CCTCC NO: M2019851, and the deposit address is No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province. This Klebsiella pneumoniae is a prior art and has been disclosed in Chinese patent application CN111548959A. Klebsiella pneumoniae The whole genome of Y7-3 was sequenced, and the accession number of its genome in the NCBI database is SAMN28890170.

[0019] To further improve Klebsiella pneumoniae The hydrogen production capacity of Y7-3 is Klebsiella pneumoniaeBy analyzing the genome data of Y7-3, a gene related to hydrogen production was found, and this gene was knocked out to obtain metabolically engineered bacteria that can improve hydrogen production.

[0020] Metabolic engineering transformation is to construct a recombinant bacterium based on Klebsiella pneumoniae Y7-3. The construction method includes constructing a recombinant plasmid and introducing the recombinant plasmid into the competent cells of Klebsiella pneumoniae Y7-3. The specific operations are as follows: (1) (S,S)-butanediol dehydrogenase / diacetyl reductase ( budC ) was inserted between the BamH I and Hind III restriction sites of the pK18mobSacB×101-2096 plasmid (with kanamycin resistance and modified vector) to obtain the recombinant plasmid pK18mobSacB×101-Δ budC -2096; (S,S)-butanediol dehydrogenase / diacetyl reductase ( budC ) is shown in SEQ ID NO.1, budC The homology arm gene sequence is shown in SEQ ID NO.2: SEQ ID NO.1(gene): 5’-ATGAAAAAAGTCGCATTTGTAACCGGCGCAGGCCAGGGGATTGGTAAAGCCATTGCCCTGCGTCTGGCCAATGACGGGTTTGCTGTTGCCGTGGCAGATTACAACGCGGAAACCGCCCATGCGGTAGCCGACGAGATCAATCACGCACATGGTAAGGGCAGCGCCATTGCGGTAACGGTGGATGTTGCCGATCGCGAGCGGGTTTTTGCCGCCGTAGAAGAGGCCAGGACAAAACTGCAAGGTTTTGATGTGATCGTCAATAACGCGGGCGTCGCGCCTTCTACTCCGATTGAGTCGATTACTGAAGCGGTGGTGGATAAGGTTTATAACATCAACGTGAAAGGCGTGATTTGGGGGATCCAGGCGGCTGTCAACGCGTTTAAAGCGGAAAAACACGGCGGCAAGATCATCAATGCCTGTTCGCAGGCCGGGCATGTGGGTAACCCGGAACTGGCGGTCTACAGCTCCAGTAAGTTTGCTGTGCGTGGTCTGACGCAAACCGCGGCGCGGGATCTGGCCCCGTTGGGGATTACCGTTAACGGCTATTGCCCGGGAATTGTTAAAACGCCGATGTGGGCGGAAATCGATCGTCAGGTGTCAGAAGCAGCAGGCAAACAACCGGGCTACGGTACGGAACAATTTGCCAAACGCATTACGCTGGGTCGCTTGTCGGAACCGGAAGATGTGGCGGCTTGTGTCTCATACCTTGCCGGGCCGGACTCGGATTATATGACAGGCCAGTCGCTGCTGATTGATGGAGGTATGGTGTTTAACTAA-3’ SEQ ID NO.2( budC homologous arm gene): 5’-GCCCGCTACCTGTACAGCTTCCGCGCCCGCCAGGTGATGATATCCAACGGCCAGCAGACCATGGGCGTCGCCCTACCCTGGGCCATCGGCGCCTGGCTGGTCAATCCTGAGCGCAAAGTGGTCTCCGTCTCCGGCGACGGCGGCTTCCTGCAGTCGAGCATGGAGCTGGAGACCGCCGTCCGCCTGAAAGCCAACGTGCTGCACCTGATCTGGGTCGATAACGGCTACAACATGGTCGCTATCCAGGAAGAGAAAAAATATCAGCGCCTGTCCGGCGTCGAGTTCGGGCCGATGGATTTTAAAGCCTATGCCGAATCCTTCGGCGCGAAAGGGTTTGCCGTGGAAAGCGCCGAGGCGCTGGAGCCGACCCTGCGCGCGGCGATGGACGTCGACGGCCCGGCGGTAGTGGCCATCCCGGTGGATTATCGCGATAACCCGCTGCTGATGGGCCAGCTGCATCTGAGTCAGATTCTGTAAGTCATCACAATAAGGAAAGGAAAAATAAAAAAAGCTCTGACATGGCTTGCCCCTGCTTTCGCGCAGGGGCTTTTTTTGGTTTGGGTGTAAGTGTAAGCATCCCGGAGAAACGAAGCATCGATATTTGAGGGCTTCTGGCGTTCTCACTTA CGCTTCGACACGACGTGGGCAATCTGACTGGGATGAAGGTCTGATTTGAGCGAGGAGCGGAAGTTCGGGAACGGGATAGCTCCATTGATGACTTTATGCTACGTGTTAAACCACAGGTAATGGAGT TGCTGCCGGAGAAAGTAGTATTCTTTAGACTGAGATCTTTTGAAAGGAACAGTAGTTGCTATAAAATTGAGGAACCAAATTTCTTTAGCTTTTAAAAAATAAAATATTATCTCTTTTAGAAATTAGA TAAGCAGGAGAAAAGCTATGATATCGGTAATAAAGGACCTATTTAGTAACCAAGTGGTTTCCGCAGTCATTCTTACTATCATTGGAGCGATTACAAAAAAGTATATTCAGTTTCATCGCAGAG-3' (2) budC Construction of gene knockout strain: After the successfully constructed pK18mobSacB×101-ΔbudC -2096 plasmid was verified and sequenced, it was electroporated into Y7-3 strain competent cells and screened on LB resistance plates (containing kanamycin with a final concentration of 100 mg / L) to obtain a single exchange strain. Then, the single colony that was screened correctly was picked into 5-10 mL LB liquid culture medium and cultured to the logarithmic phase. Then, it was spread on LB medium containing 10% sucrose and cultured until colonies grew to obtain a double exchange strain, that is, a knockout strain. budC Gene of recombinant Klebsiella pneumoniae.

[0021] The recombinant bacteria and wild Y7-3 strain (not knocked out budC The Y7-3 strain with the gene was verified by PCR, and the gel electrophoresis verification results were as follows Figure 1 As shown, lane 1 is the wild strain budC PCR products of upstream and downstream primers of the gene; Lane 2 is △ The PCR product of the upstream and downstream primers of the budC-2096 strain is 200 bp, wherein the upstream and downstream primers of the wild strain budC are shown in the sequences SEQ ID NO.3 and SEQ ID NO.4: SEQ ID NO.3 (budC-F): 5'-ACGACGGCCAGTGCCAAGCTTCCATTGTTACTGACACTCTGCGC-3' SEQ ID NO.4 (budC-R): 5'- GAGCTCGGTACCCGGGGATCCGCCCGCTACCTTTACAGCTTC-3' △ The upstream and downstream primers of budC-2096 strain are shown in SEQ ID NO.5 and SEQ ID NO.6: SEQ ID NO.5( △ budC-2096-F): 5'-TCTACTATCAATAGAGGGTTCGTTTTACC-3' SEQ ID NO.6( △ budC-2096-R): 5'-CGGTAGTGGCCATCCCG-3' By Figure 1 The comparison between lane 1 and lane 2 shows that the Klebsiella pneumoniae recombinant bacteria obtained in this example budC The gene has been successfully knocked out.

[0022] The preparation and electroporation method of Klebsiella pneumoniae Y7-3 competent cells in the above steps: ① Pick a single colony and culture it in LB medium at 37℃ on a shaker for 12 h; ② Take 1 mL and transfer it to 100 mL LB medium and culture it vigorously on a shaker at 37℃ until OD 600 =0.6 (about 4 h); ③ Transfer the cultured bacterial solution to a 50 mL centrifuge tube and centrifuge at 8000 rpm and 4℃ for 5 min; ④ Discard the supernatant, add 5 mL of pre-cooled and sterilized 10% glycerol to resuspend the cells, and repeat the operation three times; ⑤ Discard the supernatant, add 1 mL of pre-cooled and sterilized 10% glycerol to resuspend the cells; ⑥ Aliquot into sterile 1.5 mL centrifuge tubes, 100 μL per centrifuge tube, and freeze in a -70℃ refrigerator; ⑦ Electrotransformation, the electrotransformation conditions are: 2.5 KV, 800 Ω, 1 ms.

[0023] The obtained Klebsiella pneumoniae recombinant bacteria were named: Klebsiella pneumoniae Y7-3-ΔbudC-2096 was deposited in the Guangdong Provincial Microbiological Culture Collection Center on June 28, 2024, with the deposit number GDMCC NO: 64811, and the deposit address is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou.

[0024] This example also measures the hydrogen production of the recombinant bacteria obtained above, including: 1. Fermentation and cultivation of recombinant bacteria The recombinant bacteria obtained above were activated in resistance culture medium plates, and then inoculated into seed culture medium, and cultured at 37°C and 180 rpm in a shaking incubator for 12-16 hours to obtain seed solution; The solvent of the seed culture medium is water, and the solutes are: 10 g / L tryptone, 10 g / L sodium chloride, and 5 g / L yeast extract powder; the pH value is 7.0; add 20 mL of seed culture medium to a 100 mL cillin bottle, evacuate and fill with nitrogen to remove oxygen to ensure an anaerobic environment, and sterilize in a high-pressure steam sterilizer for use. Inoculate 5% of the seed liquid under sterile conditions, and culture in a constant temperature incubator at 37°C and 180 rpm for 24 h to determine the hydrogen content; Resistance medium plate: Add kanamycin (final concentration 100 μg / mL) and 20 g / L agar powder to the seed medium.

[0025] 2. Determination of hydrogen content in fermentation gas Fermentation gas collection: Use a 50 mL clean and sterile syringe to extract all the fermentation gas from the sealed vial, transfer it to a gas collection bag, and use the syringe to measure the total amount of gas during the fermentation process; Determination of hydrogen content: Fermentation gas was detected using gas chromatography, the chromatographic model was SP-3420A, the chromatographic column model was TDX-1 filling column, the column temperature was 150°C, the detector temperature was 160°C, the hot wire was 160°C, and high-purity argon was used as the carrier gas; The hydrogen content test results are as follows: Figure 2 As shown in the figure, it can be seen that compared with the control group ( Klebsiella pneumoniae Y7-3) compared to Klebsiella pneumoniae The hydrogen molar yield of Y7-3-ΔbudC-2096 increased by 50.10%, indicating budC Gene knockout can significantly increase the hydrogen production of Klebsiella pneumoniae Y7-3.

[0026] The above embodiment is only one of the preferred implementation modes of the present invention and should not be used to limit the protection scope of the present invention. Any changes or modifications that are made to the main design concept and spirit of the present invention and have no substantive significance, and the technical problems they solve are still consistent with the present invention, should be included in the protection scope of the present invention.

Claims

1. A recombinant Klebsiella pneumoniae with high hydrogen production capacity, characterized in that: Klebsiella pneumoniae ( Klebsiella pneumoniae )Y7-3 is the starting strain, and the sequence number is SEQ ID NO.

1. budC Gene acquired.

2. A recombinant Klebsiella pneumoniae with high hydrogen production capacity according to claim 1, characterized in that: The recombinant Klebsiella pneumoniae was named ( Klebsiella pneumoniae ) Y7-3-ΔbudC-2096, and was deposited in Guangdong Provincial Microbiological Culture Collection Center on June 28, 2024, with the deposit number GDMCC NO: 64811, and the deposit address is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou.

3. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production ability according to claim 2, characterized in that: include: S1: budC The homologous arm gene of the gene was inserted into a plasmid with kanamycin resistance to obtain a recombinant plasmid, and the recombinant plasmid was verified and sequenced; S2: Transform the recombinant plasmid after verification and sequencing into ( Klebsiella pneumoniae )Y7-3 strain competent cells, and primary screening was performed on a solid resistance plate containing kanamycin resistance to obtain a single exchange strain; S3: The single-exchange strain is spread on a sucrose plate to obtain a double-exchange strain, that is, the recombinant Klebsiella pneumoniae is obtained.

4. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production ability according to claim 3, characterized in that: The plasmid in step S1 is pK18mobSacB×101-2096 plasmid, and budC The homology arm gene was inserted between the BamH I and Hind III restriction sites of the plasmid.

5. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production ability according to claim 4, characterized in that: In step S2 ( Klebsiella pneumoniae ) The method for preparing competent cells of Y7-3 strain is as follows: S21: Pick ( Klebsiella pneumoniae ) A single colony of Y7-3 was cultured in LB medium at 37°C on a shaker for 12 h; S22: Take 1 mL of the bacterial culture after shaking and transfer it to 100 mL of LB medium. Shake vigorously at 37°C until OD 600 =0.6; S23: Transfer the cultured bacterial solution in step S22 to a 50 mL centrifuge tube, centrifuge at 8000 rpm and 4°C for 5 min; discard the supernatant, add 5 mL of pre-cooled and sterilized 10% glycerol to resuspend the cells, repeat the operation three times, and then resuspend with 1 mL of pre-cooled 10% sterile glycerol, and then aliquot to obtain ( Klebsiella pneumoniae ) Competent cells of Y7-3 strain.

6. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production ability according to claim 5, characterized in that: The solid resistance plate in step S2 contains kanamycin at a final concentration of 100 mg / L.

7. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production capacity according to claim 6, characterized in that: In step S3, the single-exchange strain needs to be cultured to the logarithmic phase and then spread on a plate containing 10% sucrose.

8. The method for constructing a recombinant Klebsiella pneumoniae with high hydrogen production ability according to any one of claims 3 to 7, characterized in that: In step S2, the recombinant plasmid is transferred into ( Klebsiella pneumoniae )Y7-3 strain competent cells; the electroporation conditions were: 2.5 KV, 800 Ω, 1 ms.

Citation Information

Patent Citations

  • Method for producing 2R,3R-butanediol by utilizing Klebsiella pneumoniae

    CN103740771A

  • Klebsiella pneumoniae and application thereof

    CN111548959A

  • Microorganism strains for the production of 2,3-butanediol

    WO2013076144A2